Glenmede Investment Management, LP Biolife Solutions Inc Transaction History
Glenmede Investment Management, LP
- $19.8 Trillion
- Q2 2025
A detailed history of Glenmede Investment Management, LP transactions in Biolife Solutions Inc stock. As of the latest transaction made, Glenmede Investment Management, LP holds 12,547 shares of BLFS stock, worth $336,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,547Holding current value
$336,259% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BLFS
# of Institutions
205Shares Held
50.2MCall Options Held
0Put Options Held
0-
Casdin Capital, LLC New York, NY7.71MShares$207 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$147 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.25MShares$114 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$96 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$77.6 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.14B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...